Skip to main content
Premium Trial:

Request an Annual Quote

LabKey Software Joins Microsoft's BioIT Alliance

NEW YORK (GenomeWeb News) — Seattle-based firm LabKey Software, a maker of open-source software for researchers working on large-scale, collaborative projects, said today that it has joined the BioIT Alliance.
 
The Microsoft-led BioIT Alliance is a consortium of software and biotechnology companies that are working together to advance personalized medicine and drug development using the Microsoft platform.
 
Among LabKey’s current customers are the Fred Hutchinson Cancer Research Center, the Bill and Melinda Gates Foundation-funded Center for HIV/AIDS Vaccine Immunology, and the Statistical Center for HIV/AIDS Research and Prevention.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.